Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

计划入组 99 人 · 首次发布于 2019 年 10 月 29 日

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

计划入组 62 人 · 首次发布于 2019 年 5 月 9 日

Phase 1 Study of ACE-083 in Healthy Subjects

计划入组 58 人 · 首次发布于 2014 年 10 月 6 日

ACE-86225106

ACE-16229210

ACE-1655

ACE Running LLC

United States

ACE VISION GROUP INC.

United States

Ace Cells Lab Limited

Arcoris Bio Raises CHF 6.3 Million to Advance MUSE Nanotechnology Platform for Digital Pathology

Johnson & Johnson Acquires V-Wave, Bolstering Heart Failure Portfolio with Ventura Shunt

ACE Inhibitors Show Significant Mortality Reduction in Idiopathic Pulmonary Fibrosis Patients